CLINICAL UTILITY AND PROGNOSTIC VALUE OF POST-TRANSPLANT TUMOR MOLECULAR PROFILING

Ashton Connor:Surgery,Houston Methodist Hospital,Houston,United States|Ahmed Elaileh:Surgery,Houston Methodist Hospital,Houston,United States|Samar Semaan:Surgery,Houston Methodist Hospital,Houston,United States|Elsie Rizk:Surgery,Houston Methodist Hospital,Houston,United States|Youssef Dib:Surgery,Houston Methodist Hospital,Houston,United States|Souhail Thabet:Surgery,Houston Methodist Hospital,Houston,United States|Jason Todd:Surgery,Houston Methodist Hospital,Houston,United States|Julie Luczon:Surgery,Houston Methodist Hospital,Houston,United States|Jordan Frosch:Surgery,Houston Methodist Hospital,Houston,United States|Jenny Blackman:Surgery,Houston Methodist Hospital,Houston,United States|Brittney Armstrong:Surgery,Houston Methodist Hospital,Houston,United States|Tiffani Arriazola:Surgery,Houston Methodist Hospital,Houston,United States|Tristan Waddy:Surgery,Houston Methodist Hospital,Houston,United States|Sudha Kodali:Medicine,Houston Methodist Hospital,Houston,United States|David Victor :Medicine,Houston Methodist Hospital,Houston,United States|Kirk Heyne:Medicine,Houston Methodist Hospital,Houston,United States|Maen Abdelrahim:Medicine,Houston Methodist Hospital,Houston,United States|Sadhna Dhingra:Pathology,Houston Methodist Hospital,Houston,United States|Mary Schwartz:Pathology,Houston Methodist Hospital,Houston,United States|Hao Liu:Surgery,Houston Methodist Hospital,Houston,United States|Yifan Wang:Surgery,Houston Methodist Hospital,Houston,United States|Sherif Armanyous:Surgery,Houston Methodist Hospital,Houston,United States|Caroline Simon:Surgery,Houston Methodist Hospital,Houston,United States|Yee Lee Cheah:Surgery,Houston Methodist Hospital,Houston,United States|Constance Mobley:Surgery,Houston Methodist Hospital,Houston,United States|Ashish Saharia:Surgery,Houston Methodist Hospital,Houston,United States|Timothy Newhook:Surgery,MD Anderson Cancer Center,Houston,United States|Ahmed Kaseb:Medicine,MD Anderson Cancer Center,Houston,United States|Milind Javle:Medicine,MD Anderson Cancer Center,Houston,United States|Jean-Nicolas Vauthey:Surgery,MD Anderson Cancer Center,Houston,United States|Mahinur Mattohti:Research Institute,Houston Methodist Hospital,Houston,United States|Xian Li:Research Institute,Houston Methodist Hospital,Houston,United States|Osama Gaber:Surgery,Houston Methodist Hospital,Houston,United States|Mark Ghobrial:Surgery,Houston Methodist Hospital,Houston,United States

CELL CYCLE PATHWAY ALTERATIONS PREDICT REDUCED SURVIVAL AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA

Ashton Connor:Surgery,Houston Methodist Hospital,Houston,United States|Ahmed Elaileh:Surgery,Houston Methodist Hospital,Houston,United States|Samar Semaan:Surgery,Houston Methodist Hospital,Houston,United States|Elsie Rizk:Surgery,Houston Methodist Hospital,Houston,United States|Youssef Dib:Surgery,Houston Methodist Hospital,Houston,United States|Souhail Thabet:Surgery,Houston Methodist Hospital,Houston,United States|Jason Todd:Surgery,Houston Methodist Hospital,Houston,United States|Julie Luczon:Surgery,Houston Methodist Hospital,Houston,United States|Jordan Frosch:Surgery,Houston Methodist Hospital,Houston,United States|Jenny Blackman:Surgery,Houston Methodist Hospital,Houston,United States|Brittney Armstrong:Surgery,Houston Methodist Hospital,Houston,United States|Tiffani Arriazola:Surgery,Houston Methodist Hospital,Houston,United States|Tristan Waddy:Surgery,Houston Methodist Hospital,Houston,United States|Sudha Kodali:Medicine,Houston Methodist Hospital,Houston,United States|David Victor :Medicine,Houston Methodist Hospital,Houston,United States|Kirk Heyne:Medicine,Houston Methodist Hospital,Houston,United States|Maen Abdelrahim:Medicine,Houston Methodist Hospital,Houston,United States|Sadhna Dhingra:Pathology,Houston Methodist Hospital,Houston,United States|Mary Schwartz:Pathology,Houston Methodist Hospital,Houston,United States|Hao Liu:Surgery,Houston Methodist Hospital,Houston,United States|Yifan Wang:Surgery,Houston Methodist Hospital,Houston,United States|Sherif Armanyous:Surgery,Houston Methodist Hospital,Houston,United States|Caroline Simon:Surgery,Houston Methodist Hospital,Houston,United States|Yee Lee Cheah:Surgery,Houston Methodist Hospital,Houston,United States|Constance Mobley:Surgery,Houston Methodist Hospital,Houston,United States|Ashish Saharia:Surgery,Houston Methodist Hospital,Houston,United States|Timothy Newhook:Surgery,MD Anderson Cancer Center,Houston,United States|Ahmed Kaseb:Medicine,MD Anderson Cancer Center,Houston,United States|Milind Javle:Medicine,MD Anderson Cancer Center,Houston,United States|Jean-Nicolas Vauthey:Surgery,MD Anderson Cancer Center,Houston,United States|Mahinur Mattohti:Research Institute,Houston Methodist Hospital,Houston,United States|Xian Li:Research Institute,Houston Methodist Hospital,Houston,United States|Osama Gaber:Surgery,Houston Methodist Hospital,Houston,United States|Mark Ghobrial:Surgery,Houston Methodist Hospital,Houston,United States

POST-TRANSPLANT MOLECULAR PROFILING OF CHOLANGIOCARCINOMA IDENTIFIES TP53 AS A PROGNOSTIC BIOMARKER

Ashton Connor:Surgery,Houston Methodist Hospital,Houston,United States|Ahmed Elaileh:Surgery,Houston Methodist Hospital,Houston,United States|Samar Semaan:Surgery,Houston Methodist Hospital,Houston,United States|Elsie Rizk:Surgery,Houston Methodist Hospital,Houston,United States|Youssef Dib:Surgery,Houston Methodist Hospital,Houston,United States|Souhail Thabet:Surgery,Houston Methodist Hospital,Houston,United States|Jason Todd:Surgery,Houston Methodist Hospital,Houston,United States|Julie Luczon:Surgery,Houston Methodist Hospital,Houston,United States|Jordan Frosch:Surgery,Houston Methodist Hospital,Houston,United States|Jenny Blackman:Surgery,Houston Methodist Hospital,Houston,United States|Brittney Armstrong:Surgery,Houston Methodist Hospital,Houston,United States|Tiffani Arriazola:Surgery,Houston Methodist Hospital,Houston,United States|Tristan Waddy:Surgery,Houston Methodist Hospital,Houston,United States|Sudha Kodali:Medicine,Houston Methodist Hospital,Houston,United States|David Victor :Medicine,Houston Methodist Hospital,Houston,United States|Kirk Heyne:Medicine,Houston Methodist Hospital,Houston,United States|Maen Abdelrahim:Medicine,Houston Methodist Hospital,Houston,United States|Sadhna Dhingra:Pathology,Houston Methodist Hospital,Houston,United States|Mary Schwartz:Pathology,Houston Methodist Hospital,Houston,United States|Hao Liu:Surgery,Houston Methodist Hospital,Houston,United States|Yifan Wang:Surgery,Houston Methodist Hospital,Houston,United States|Sherif Armanyous:Surgery,Houston Methodist Hospital,Houston,United States|Caroline Simon:Surgery,Houston Methodist Hospital,Houston,United States|Yee Lee Cheah:Surgery,Houston Methodist Hospital,Houston,United States|Constance Mobley:Surgery,Houston Methodist Hospital,Houston,United States|Ashish Saharia:Surgery,Houston Methodist Hospital,Houston,United States|Timothy Newhook:Surgery,MD Anderson Cancer Center,Houston,United States|Ahmed Kaseb:Medicine,MD Anderson Cancer Center,Houston,United States|Milind Javle:Medicine,MD Anderson Cancer Center,Houston,United States|Jean-Nicolas Vauthey:Surgery,MD Anderson Cancer Center,Houston,United States|Mahinur Mattohti:Research Institute,Houston Methodist Hospital,Houston,United States|Xian Li:Research Institute,Houston Methodist Hospital,Houston,United States|Osama Gaber:Surgery,Houston Methodist Hospital,Houston,United States|Mark Ghobrial:Surgery,Houston Methodist Hospital,Houston,United States

A NEW ERA OF LIVER TRANSPLANTATION: THE MEASURED IMPACT OF NORMOTHERMIC MACHINE PERFUSION ON CENTER-LEVEL PERFORMANCE

Samar Semaan:Surgery,Houston Methodist Hospital,Houston,United States|Ashton Connor:Surgery,Houston Methodist Hospital,Houston,United States|Ahmed Elaileh:Surgery,Houston Methodist Hospital,Houston,United States|Youssef Dib:Surgery,Houston Methodist Hospital,Houston,United States|Souhail Thabet:Surgery,Houston Methodist Hospital,Houston,United States|Jason Todd:Surgery,Houston Methodist Hospital,Houston,United States|Sudha Kodali:Medicine,Houston Methodist Hospital,Houston,United States|David Victor :Medicine,Houston Methodist Hospital,Houston,United States|Hao Liu:Surgery,Houston Methodist Hospital,Houston,United States|Yifan Wang:Surgery,Houston Methodist Hospital,Houston,United States|Sherif Armanyous:Surgery,Houston Methodist Hospital,Houston,United States|Caroline Simon:Surgery,Houston Methodist Hospital,Houston,United States|Yee Lee Cheah:Surgery,Houston Methodist Hospital,Houston,United States|Constance Mobley:Surgery,Houston Methodist Hospital,Houston,United States|Ashish Saharia:Surgery,Houston Methodist Hospital,Houston,United States|Osama Gaber:Surgery,Houston Methodist Hospital,Houston,United States|Mark Ghobrial:Surgery,Houston Methodist Hospital,Houston,United States

BRIDGING THE LIVER TRANSPLANTATION GAP OVER A DECADE: FROM THOUSANDS IN THE UNITED KINGDOM TO HUNDREDS IN MALAYSIA- LESSONS FOR GLOBAL EQUITY IN TRANSPLANTATION

Mew Har Leong:Anaesthesiology,Queen Elizabeth Hospital Birmingham,Birmingham,United Kingdom;Anaesthesiology and Intensive Care,Hospital Selayang ,Selayang,Malaysia

CABOZANTINIB FOR RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION: A MULTICENTER CLINICAL EXPERIENCE

Chiara Mazzarelli:Hepatology & Gastroenterology Niguarda,ASST Grande Ospedale Metropolitano Niguarda,Milan,Italy|Federica Tosi:Oncology Department,ASST Grande Ospedale Metropolitano Niguarda,Milan,Italy|Federica Villa:Oncology Department,ASST Grande Ospedale Metropolitano Niguarda,Milan,Italy|Clara Di Benedetto:Division of Gastroenterology and Hepatology,Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico,Milan,Italy|Michele Sagasta:Division of Gastroenterology and Hepatology,Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico,Milan,Italy|Eleonora Alimenti:Division of Gastroenterology and Hepatology,Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico,Milan,Italy|Massimo Alberto Iavarone:Division of Gastroenterology and Hepatology,Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico,Milan,Italy;CRC "A. M. and A. Migliavacca" Center for Liver Disease, Department of Pathophysiology and Transplantation,University of Milan,Milan,Italy|Daniela Costantino:astroenterology Hepatology & Transplantation Unit,ASST Papa Giovanni XXIII Hospital,Bergamo,Italy|Massimo De Giorgio:astroenterology Hepatology & Transplantation Unit,ASST Papa Giovanni XXIII Hospital,Bergamo,Italy|Luca Saverio Belli:Hepatology & Gastroenterology Niguarda,ASST Grande Ospedale Metropolitano Niguarda,Milan,Italy

AGE-SPECIFIC RISK FACTORS OF INTRAPATIENT VARIABILITY OF TACROLIMUS IN LIVER TRANSPLANTATION: A PROPENSITY SCORE MATCHED STUDY

Saran Ochir Gongor:Surgery,Seoul National University College of Medicine,Seoul,Korea, Republic Of|Sang Hyuk Park:Surgery,Seoul National University Hospital,Seoul,Korea, Republic Of|Min Kyoung Kim:Surgery,Seoul National University Hospital,Seoul,Korea, Republic Of|Gayoung Kim:Surgery,Seoul National University Hospital,Seoul,Korea, Republic Of|Jae-Yoon Kim:Surgery,Seoul National University College of Medicine,Seoul,Korea, Republic Of;Surgery,Seoul National University Hospital,Seoul,Korea, Republic Of|Su young Hong:Surgery,Seoul National University Hospital,Seoul,Korea, Republic Of|Suk Kyun Hong:Surgery,Seoul National University College of Medicine,Seoul,Korea, Republic Of;Surgery,Seoul National University Hospital,Seoul,Korea, Republic Of|Kwang-Woong Lee:Surgery,Seoul National University College of Medicine,Seoul,Korea, Republic Of;Surgery,Seoul National University Hospital,Seoul,Korea, Republic Of|YoungRok Choi:Surgery,Seoul National University College of Medicine,Seoul,Korea, Republic Of;Surgery,Seoul National University Hospital,Seoul,Korea, Republic Of

LARGE-FOR-SIZE GRAFTS DO NOT WORSEN OUTCOMES AFTER SIDE-TO-SIDE CAVOCAVAL ANASTOMOSIS IN ADULT DECEASED-DONOR LIVER TRANSPLANTATION

Jiyoung Kim:Department of Surgery,Seoul St. Mary's Hospital,Seoul,Korea, Republic Of|Jin Ha Chun:Department of Surgery,Seoul St. Mary's Hospital,Seoul,Korea, Republic Of|Ho Joong Choi:Department of Surgery,Seoul St. Mary's Hospital,Seoul,Korea, Republic Of|Young Kyoung You:Department of Surgery,Seoul St. Mary's Hospital,Seoul,Korea, Republic Of|Eui Soo Han:Department of Surgery,Seoul St. Mary's Hospital,Seoul,Korea, Republic Of

ELEVATED PREOPERATIVE BNP IS ASSOCIATED WITH POSTOPERATIVE MAJOR ADVERSE CARDIAC EVENTS IN LIVER TRANSPLANTATION

Nattapon Sukcharoen:Department of Anesthesiology,Ronal Reagand UCLA Medical Center,Los Angeles,United States;Department of Anesthesiology,Faculty of Medicine, Thammasat University Hospital, Thammasat University,Pathum Thani,Thailand|Victor Xia:Department of Anesthesiology,Ronal Reagand UCLA Medical Center,Los Angeles,United States

COMPARATIVE PROGNOSTIC VALUE OF SKELETAL MUSCLE INDEX AND CYSTATIN C–BASED MUSCLE INDICES FOR ONE-YEAR MORTALITY IN LIVER TRANSPLANT RECIPIENTS

Sa-Jin Kang:Department of Anesthesiology and Pain Medicine,University of Ulsan College of Medicine, Asan Medical Center,Seoul,Korea, Republic Of|Hye-Mee Kwon:Department of Anesthesiology and Pain Medicine,University of Ulsan College of Medicine, Asan Medical Center,Seoul,Korea, Republic Of|Kyoung-Sun Kim:Department of Anesthesiology and Pain Medicine,University of Ulsan College of Medicine, Asan Medical Center,Seoul,Korea, Republic Of|In-Gu Jun:Department of Anesthesiology and Pain Medicine,University of Ulsan College of Medicine, Asan Medical Center,Seoul,Korea, Republic Of|Jun-Gol Song:Department of Anesthesiology and Pain Medicine,University of Ulsan College of Medicine, Asan Medical Center,Seoul,Korea, Republic Of|Gyu-Sam Hwang:Department of Anesthesiology and Pain Medicine,University of Ulsan College of Medicine, Asan Medical Center,Seoul,Korea, Republic Of